Yahoo! Finance: Biotechnology Industry News: Medivation and Astellas Provide Update on PREVAIL

Yahoo! Finance: Biotechnology Industry News The latest news on the Biotechnology industry from Yahoo! Finance

Medivation and Astellas Provide Update on PREVAIL Apr 1st 2013, 11:00 [Marketwire] - Medivation, Inc. and Astellas Pharma Inc. today announced that the companies have established an updated interim analysis plan for the PREVAIL trial, a global Phase 3 clinical trial evaluating XTANDI® ...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Yahoo! Finance: Biotechnology Industry News: NeoStem to Present at Multiple Conferences in April

Yahoo! Finance: Biotechnology Industry News The latest news on the Biotechnology industry from Yahoo! Finance

NeoStem to Present at Multiple Conferences in April Apr 1st 2013, 11:30 [GlobeNewswire] - NEW YORK -- NeoStem, Inc. (NYSE MKT:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy market, today announced that the Company and its subsidiary, Progenitor ...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Yahoo! Finance: Biotechnology Industry News: Medivation, Astellas Pharma provide update on Phase 3 PREVAIL

Yahoo! Finance: Biotechnology Industry News The latest news on the Biotechnology industry from Yahoo! Finance

Medivation, Astellas Pharma provide update on Phase 3 PREVAIL Apr 1st 2013, 11:12

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Yahoo! Finance: Biotechnology Industry News: Cytokinetics Announces Initiation of First-Time-in-Humans, Phase I Clinical Trial of CK-2127107

Yahoo! Finance: Biotechnology Industry News The latest news on the Biotechnology industry from Yahoo! Finance

Cytokinetics Announces Initiation of First-Time-in-Humans, Phase I Clinical Trial of CK-2127107 Apr 1st 2013, 11:35 [Thomson Reuters ONE] - Second Drug Candidate from Cytokinetics` Fast Skeletal Muscle Activator Program Begins Clinical Trial in Expanded Development Program South San Francisco, CA, April 1, 2013 - Cytokinetics, Incorporated ...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Wall Street Oasis - Investment Banking & Finance Community: Thank You To Our Sponsors

Wall Street Oasis - Investment Banking & Finance Community The Wall Street Finance Community where investment bankers, consultants, traders, private equity and hedge fund professionals come to learn and play.

Thank You To Our Sponsors Apr 1st 2013, 03:00 We'd like to thank the Wall Street Oasis sponsors that help keep the community free for everyone and we encourage all of you to check them out below! Veritas GMAT Prep - The Leader in GMAT Prep (10% Discount for WSO Users) Since its founding in 2002, Veritas Prep has prepared more than 50,000 students for the GMAT in more than 90 locations around the world and through interactive live online classes. Today Veritas Prep is the world's fastest–growing GMAT prep and admissions consulting provider. Ask Veritas Prep thread on WSO read more Media files: preview (image/jpeg, 0 MB)

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Yahoo! Finance: Biotechnology Industry News: Is There Any Potential Left In ACADIA Pharmaceuticals?

Yahoo! Finance: Biotechnology Industry News The latest news on the Biotechnology industry from Yahoo! Finance

Is There Any Potential Left In ACADIA Pharmaceuticals? Apr 1st 2013, 09:54

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Yahoo! Finance: Biotechnology Industry News: BioCryst Pharmaceuticals Provides Update Regarding Peramivir

Yahoo! Finance: Biotechnology Industry News The latest news on the Biotechnology industry from Yahoo! Finance

BioCryst Pharmaceuticals Provides Update Regarding Peramivir Apr 1st 2013, 10:12 [Business Wire] - BioCryst Pharmaceuticals, Inc. today announced that it received a preliminary comment letter from the U.S. Food & Drug Administration that outlines a pathway by which BioCryst could file a New Drug Application seeking regulatory approval of intravenous peramivir.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions